Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer

Cell stem cell(2020)10.1016/j.stem.2020.07.003Source: DataRank Database

Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer is a research paper published in Cell stem cell (2020). On theSindex it has a DataRank of 0. It has been cited 190 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access190 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 12.83)OA: bronzeTopics (34)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Jordi Xiol,Michael T. Dill ORCID,Wei-Chien Yuan ORCID,Riccardo Panero ORCID,Jatin Roper ORCID

Live enrichment

PubMed:32730753 PMC:PMC10114498 OpenAlex:https://openalex.org/W3046149276

Human Frontier Science Program

Grant: R01 DK099559

Human Frontier Science Program

Grant: R01 AR064036

National Institutes of Health

Grant: T32GM007226 -41

National Institutes of Health

Grant: F31CA235893

Human Frontier Science Program

Grant: LT000845 /2014-L

NIGMS NIH HHS

Grant: T32 GM007226

NCI NIH HHS

Grant: P30 CA014051

FWCI

12.83

Citation Percentile

1.0%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1934590920303416/pdf

BRONZEhttp://www.cell.com/article/S1934590920303416/pdf

publisherhttp://www.cell.com/article/S1934590920303416/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1934590920303416?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590920303416?httpAccept=text/plain

Fields of Study

Hippo pathway signaling and YAP/TAZWnt/β-catenin signaling in development and cancerBiologyMedicine

MeSH Terms

AnimalsPhosphoproteinsTranscription FactorsColorectal NeoplasmsCell Cycle ProteinsAdaptor Proteins, Signal TransducingCell ProliferationMice

Keywords

BiologyLGR5Wnt signaling pathwayHippo signaling pathwayCancer researchColorectal cancerReprogrammingStem cellCell biologyKinaseTranscription factorMouse model of colorectal and intestinal cancerCancer stem cellCancerSignal transductionCellGeneticsRegenerationMetastasisWnt signalingIntestinal Stem CellsHippo Signaling

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of YAP represses intestinal inflammation through epigenetic silencing of JMJD3

10.6084/m9.figshare.26670411.v1figshare

Additional file 1 of YAP represses intestinal inflammation through epigenetic silencing of JMJD3

10.6084/m9.figshare.26670411figshare

Additional file 1 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720019.v1figshare

Additional file 1 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720019figshare

Additional file 2 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720022.v1figshare

Additional file 2 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720022figshare

Additional file 3 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720025figshare

Additional file 3 of The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

10.6084/m9.figshare.26720025.v1figshare

Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer

FAIR Checklist

Authors (14)

Funding (7 grants)

Impact

Open Access

Topics

Linked Datasets (8)

Annotations (Europe PMC)